Persistence Pays Off With US Approval Of Aveo’s Fotivda In RCC

 
• By Jessica Merrill

The approval marks the first commercial launch for Aveo in the US, but tivozanib has shown modest efficacy in cancer and the approval is relegated to later lines.

Sisyphus metaphor. Man rolling huge concrete ball up hill.
Aveo has pushed Fotivda onto FDA approval • Source: Shutterstock

More from Anticancer

More from Therapy Areas